Content related to Children’s Hospital Los Angeles Develops Liquid Biopsy Test for Pediatric Solid Tumors

Children’s Hospital Los Angeles (CHLA) and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay

Research performed over the last several decades has led to an increased understanding of the genetics of cancer. The clinical application of this knowledge for pediatric cancer has lagged behind

Peter Chiarelli, MD, DPhil, is combining chemistry, physics and nanoscience to find new therapies for diffuse intrinsic pontine gliomas.

A new study finds a reason, paving the way for the development of new, more effective treatments.